Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chromene derivatives in psoriasis skin biopsy gene expression study
NL-OMON43448Active, not recruiting
- Sponsor
- Artax Biopharma
- Start
- Feb 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in plaque psoriasis, sponsored by Artax Biopharma. Primary endpoints: Gene expression regulation after treatment with chromene derivatives and Morphology in full-thickness lesional skin biopsies. Started Feb 2016; status: active, not recruiting.
02
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NL-OMON43448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43448.